Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disorder in which the body’s immune system attacks and damages the myelin sheath surrounding the nerves in the central nervous system (CNS). This damage disrupts the transmission of signals between the brain and other parts of the body, leading to a wide range of physical and cognitive symptoms such as muscle weakness, vision problems, fatigue, numbness, impaired speech and balance, as well as cognitive decline. MS can have a significant impact on a person’s quality of life, and is associated with an increased risk of depression. Treatment for MS aims to reduce the impact of symptoms and slow the progression of the disease. MS is most common in young adults, and affects approximately 2.5 million people worldwide.
← Journal of Spine and Neuroscience